Jonas Ghouse1, Christian Theil Have2, Peter Weeke1, Jonas Bille Nielsen1, Gustav Ahlberg1, Marie Balslev-Harder2, Emil Vincent Appel2, Tea Skaaby3, Søren-Peter Olesen4, Niels Grarup2, Allan Linneberg5, Oluf Pedersen2, Stig Haunsø6, Jesper Hastrup Svendsen6, Torben Hansen2, Jørgen Kim Kanters7, Morten Salling Olesen8. 1. The Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark. 2. The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3. Research Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark. 4. The Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark. 5. Research Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark Department of Clinical Experimental Research, Glostrup University Hospital, Denmark Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. 6. The Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark Department of Medicine and Surgery, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. 7. Laboratory of Experimental Cardiology, Department of Biomedicine, University of Copenhagen, Copenhagen, Denmark Department of Cardiology, Herlev and Gentofte University Hospitals, Copenhagen, Denmark. 8. The Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark morten.salling.olesen@gmail.com.
Abstract
AIMS: We studied whether variants previously associated with congenital long QT syndrome (cLQTS) have an effect on the QTc interval in a Danish population sample. Furthermore, we assessed whether carriers of variants in cLQTS-associated genes are more prone to experience syncope compared with non-carriers and whether carriers have an increased mortality compared with non-carriers. METHODS AND RESULTS: All genetic variants previously associated with cLQTS were surveyed using the Human Gene Mutation Database. We screened a Danish population-based sample with available whole-exome sequencing data (n = 870) and genotype array data (n = 6161) for putative cLQTS genetic variants. In total, 33 of 1358 variants previously reported to associate with cLQTS were identified. Of these, 10 variants were found in 8 or more individuals. Electrocardiogram results showed normal mean QTc intervals in carriers compared with non-carriers. Syncope data analysis between variant and non-variant carriers showed that 4 of 227 (1.8%) and 95 of 5861 (1.6%) individuals, respectively, had experienced syncope during follow-up (P = 0.80). There was no significant difference in overall mortality rates between carriers [7/217 (3.2%)] and non-carriers [301/6453 (4.7%)] (P = 0.24). CONCLUSION: We present QTc data and register data, indicating that 26 cLQTS-associated variants neither had any effect on the QTc intervals nor on syncope propensity or overall mortality. Based on the frequency of individual gene variants, we suggest that the 10 variants frequently identified, assumed to relate to cLQTS, are less likely to associate with a dominant monogenic form of the disease. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: We studied whether variants previously associated with congenital long QT syndrome (cLQTS) have an effect on the QTc interval in a Danish population sample. Furthermore, we assessed whether carriers of variants in cLQTS-associated genes are more prone to experience syncope compared with non-carriers and whether carriers have an increased mortality compared with non-carriers. METHODS AND RESULTS: All genetic variants previously associated with cLQTS were surveyed using the Human Gene Mutation Database. We screened a Danish population-based sample with available whole-exome sequencing data (n = 870) and genotype array data (n = 6161) for putative cLQTS genetic variants. In total, 33 of 1358 variants previously reported to associate with cLQTS were identified. Of these, 10 variants were found in 8 or more individuals. Electrocardiogram results showed normal mean QTc intervals in carriers compared with non-carriers. Syncope data analysis between variant and non-variant carriers showed that 4 of 227 (1.8%) and 95 of 5861 (1.6%) individuals, respectively, had experienced syncope during follow-up (P = 0.80). There was no significant difference in overall mortality rates between carriers [7/217 (3.2%)] and non-carriers [301/6453 (4.7%)] (P = 0.24). CONCLUSION: We present QTc data and register data, indicating that 26 cLQTS-associated variants neither had any effect on the QTc intervals nor on syncope propensity or overall mortality. Based on the frequency of individual gene variants, we suggest that the 10 variants frequently identified, assumed to relate to cLQTS, are less likely to associate with a dominant monogenic form of the disease. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Rabia Faridi; Risa Tona; Alessandra Brofferio; Michael Hoa; Rafal Olszewski; Isabelle Schrauwen; Muhammad Z K Assir; Akhtar A Bandesha; Asma A Khan; Atteeq U Rehman; Carmen Brewer; Wasim Ahmed; Suzanne M Leal; Sheikh Riazuddin; Steven E Boyden; Thomas B Friedman Journal: Hum Mutat Date: 2018-12-12 Impact factor: 4.878
Authors: Christian Paludan-Müller; Jonas Ghouse; Oliver B Vad; Cecilie B Herfelt; Pia Lundegaard; Gustav Ahlberg; Nicole Schmitt; Jesper H Svendsen; Stig Haunsø; Henning Bundgaard; Torben Hansen; Jørgen K Kanters; Morten S Olesen Journal: Eur J Hum Genet Date: 2019-05-01 Impact factor: 4.246
Authors: Nicole S York; Juan C Sanchez-Arias; Alexa C H McAdam; Joel E Rivera; Laura T Arbour; Leigh Anne Swayne Journal: Front Cardiovasc Med Date: 2022-08-04
Authors: Laura Andreasen; Gustav Ahlberg; Chuyi Tang; Charlotte Andreasen; Jacob P Hartmann; Jacob Tfelt-Hansen; Elijah R Behr; Steen Pehrson; Stig Haunsø; Peter E Weeke; Thomas Jespersen; Morten S Olesen; Jesper H Svendsen Journal: Eur J Hum Genet Date: 2018-02-02 Impact factor: 4.246
Authors: Jan M Friedman; Martina C Cornel; Aaron J Goldenberg; Karla J Lister; Karine Sénécal; Danya F Vears Journal: BMC Med Genomics Date: 2017-02-21 Impact factor: 3.063
Authors: Thomas M Roston; Taylor Cunningham; Anna Lehman; Zachary W Laksman; Andrew D Krahn; Shubhayan Sanatani Journal: Clin Med Insights Cardiol Date: 2017-03-16